35 articles for H Zheng
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
59
Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases.

Intra-Cellular Therapies
27
9-Dihydroerythromycins as non-antibiotic motilin receptor agonists.

Kosan Biosciences
25
Structure-activity relationships of 9-substituted-9-dihydroerythromycin-based motilin agonists: optimizing for potency and safety.

Kosan Biosciences
7
Nicotinic acid receptor agonists differentially activate downstream effectors.

Arena Pharmaceuticals
5
Synthesis and biological evaluation of novel 5-benzylidenethiazolidine-2,4-dione derivatives for the treatment of inflammatory diseases.

Sichuan University
32
Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors.

Tianjin University of Science and Technology
9
Novel indoline-1- or 3,4-dihydroquinoline-1(2H)-substituted carbothiohydrazides as TPO receptor agonists.

Shanghai Hengrui Pharmaceuticals
5
Synthesis and biological evaluation of oxoindolin-3-ylidene ethyl benzothiohydrazides as non-peptide TPO mimics.

Shanghai Hengrui Pharmaceuticals
1
Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.

Institute of Science
5
Halogenated retinoid derivatives as dual RARα and RXRα modulators for treating acute promyelocytic leukemia cells.

Xiamen University
2
Discovery of Novel PROTAC-Based HPK1 Degraders with High Potency and Selectivity for Cancer Immunotherapy.

Huadong Medicine
2
Design and Evaluation of 3-Phenyloxetane Derivative Agonists of the Glucagon-Like Peptide-1 Receptor.

Huadong Medicine Company Limited
2
The Development of a Highly Potent and Selective Human Toll-like Receptor 2 Agonist: Synthesis and Biological Evaluation of CaLGL-1 and Its Derivatives.

Lanzhou University
39
Discovery of Novel Macrocyclic MERTK/AXL Dual Inhibitors.

University of North Carolina
19
Discovery of ITI-333, a Novel Orally Bioavailable Molecule Targeting Multiple Receptors for the Treatment of Pain and Other Disorders.

Intra-Cellular Therapies, Inc.
30
Alkyl-substituted N-methylaryl-N'-aryl-4-aminobenzamides: A new series of small molecule inhibitors for Wip1 phosphatase.

Niddk
1
A TNF-α blocking peptide that reduces NF-κB and MAPK activity for attenuating inflammation.

Changchun University of Science and Technology
10
Quinazoline-based hydroxamic acid derivatives as dual histone methylation and deacetylation inhibitors for potential anticancer agents.

Tsinghua University
36
UNC5293, a potent, orally available and highly MERTK-selective inhibitor.

University of North Carolina at Chapel Hill
95
Discovery and Optimization of 2

National Center For Advancing Translational Sciences
11
Naphthacemycins from a

Hebei Medical University
50
Discovery of furyl/thienyl β-carboline derivatives as potent and selective PDE5 inhibitors with excellent vasorelaxant effect.

Shandong University
6
Terpenoids with vasorelaxant effects from the Chinese liverwort Scapania carinthiaca.

Shandong University
21
Design and synthesis of furyl/thineyl pyrroloquinolones based on natural alkaloid perlolyrine, lead to the discovery of potent and selective PDE5 inhibitors.

Shandong University
6
Synthesis and biological evaluation of 6-hydroxyl C-aryl glucoside derivatives as novel sodium glucose co-transporter 2 (SGLT2) inhibitors.

Shandong University
26
Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition.

Effector Therapeutics
45
Discovery of Potent Orally Active Protease-Activated Receptor 1 (PAR1) Antagonists Based on Andrographolide.

Shandong University
40
NOVEL COMPOUNDS

Sitryx Therapeutics
92
Zaindole derivatives and their use as ERK kinase inhibitors

Agv Discovery
21
Kinase inhibitors and their use in cancer therapy

Technische UniversitÄT Dortmund
40
Benzimidazole derivates useful as inhibitors of mammalian histone deacetylase activity

Kancera
14
Pyridazinones as DAAO enzyme inhibitors

Takeda Pharmaceutical
585
Heteroaryl substituted nicotinamide compounds

Bristol Myers Squibb
5
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties

University of Michigan
18
2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists.

Universita Degli Studi Di Milano